Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $160.2500 (-7.04%) ($160.2500 - $160.2500) on Tue. Feb. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.68% (three month average) | RSI | 57 | Latest Price | $160.2500(-7.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -4.8% a day on average for past five trading days. | Weekly Trend | LGND advances 2.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(52%) | Factors Impacting LGND price | LGND will decline at least -2.34% in a week (0% probabilities). VIXM(-27%) UUP(-17%) VXX(-16%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.34% (StdDev 4.68%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $174.16 | 5 Day Moving Average | $187.7(-14.62%) | 10 Day Moving Average | $188.06(-14.79%) | 20 Day Moving Average | $174.16(-7.99%) | To recent high | -25.8% | To recent low | 96.8% | Market Cap | $2.575b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |